TenderlineUK
Procurement Intelligence
Search
Find a TenderAwarded
Published 2 Aug 2024, 10:51 BST

Official UK procurement notice

NP39724 Generic and Biosimilar Cancer Medicines

Official notice

Authority: The Common Services Agency (more commonly known as NHS National Services Scotland) (NSS) (NHS & healthcare)·Consortium: 2 public authorities

Framework agreement43 lotsGoodsOpen procedureSME suitable
Sectors: Medical Devices & Pharma (33) Delivery: UKScotland (UKM)
Framework ceiling (notional)£57,386,767total for 43 lots · framework ceiling, not attributable revenue
Submissions closed 2 Sept 2024awarded 13 Jan 2025
Lots 43see the lot list below

What is being bought43 lots · detail below

Published requirement description

Supply of Generic and Biosimilar Cancer Medicines to NHS Scotland.

CPV: Pharmaceutical products

How this framework works

From the published notice
Bids received
4 bids on the busiest of 25 lots · 35 suppliers appointed

Lots and requirements (43)Procurement structure

25 of 43 loaded on this page

Showing the first 25 of 43 published lots; the full list is in the JSON and Markdown mirrors of this notice. 43 lots · all with a published value · same evaluation weights on every lot.

Every one of these 2 lots carries the same published figure, £9,053,054: it is the framework's maximum for the whole notice, not each lot's own budget, and no share per lot is published. The cards below say ceiling above rather than repeat it.

Lot #1Bendamustine Powder For Solution For InfusionAwardedRenewalPublished value£123,054

Supply of Bendamustine Powder For Solution For Infusion to NHS Scotland. The Authority intends to award this Lot as a single supplier

framework. Full details of Goods and volumes can be found within the ITT documents.

Delivery: Scotland · All entities constituted pursuant to the National Health Service (Scotland) Act 1978, and any Integrated Joint Boards established pursuant to the new Public Bodies (Joint Working) Scotland Act 2014.
Extensions: This framework includes the option to extend for any number of periods, up to a maximum overall period of twenty-four (24) months upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire.Variant bids: not allowed
33600000 Pharmaceutical products
Lot #2Capecitabine TabletsAwardedRenewalPublished value£723,873

Supply of Capecitabine Tablets to NHS Scotland. The Authority intends to award this Lot as a single supplier framework. Full details of

Goods and volumes can be found within the ITT documents.

Delivery: Scotland · All entities constituted pursuant to the National Health Service (Scotland) Act 1978, and any Integrated Joint Boards established pursuant to the new Public Bodies (Joint Working) Scotland Act 2014.
Extensions: This framework includes the option to extend for any number of periods, up to a maximum overall period of twenty-four (24) months upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire.Variant bids: not allowed
33600000 Pharmaceutical products
Lot #3Carboplatin InjectionsAwardedRenewalPublished value£676,953

Supply of Carboplatin Injections to NHS Scotland. The Authority intends to award this Lot as a single supplier framework . Full details of

Goods and volumes can be found within the ITT documents.

Delivery: Scotland · All entities constituted pursuant to the National Health Service (Scotland) Act 1978, and any Integrated Joint Boards established pursuant to the new Public Bodies (Joint Working) Scotland Act 2014.
Extensions: This framework includes the option to extend for any number of periods, up to a maximum overall period of twenty-four (24) months upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire.Variant bids: not allowed
33600000 Pharmaceutical products
Lot #4Cisplatin InjectionsAwardedRenewalPublished value£1,424,495

Supply of Cisplatin Injections to NHS Scotland. The Authority intends to award this Lot as a single supplier framework. Full details of

Goods and volumes can be found within the ITT documents.

Delivery: Scotland · All entities constituted pursuant to the National Health Service (Scotland) Act 1978, and any Integrated Joint Boards established pursuant to the new Public Bodies (Joint Working) Scotland Act 2014.
Extensions: This framework includes the option to extend for any number of periods, up to a maximum overall period of twenty-four (24) months upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire.Variant bids: not allowed
33600000 Pharmaceutical products
Lot #5Cyclophosphamide Injection, Powder For ReconstitutionAwardedRenewalPublished value£304,922

Supply of Cyclophosphamide Injection, Powder For Reconstitution to NHS Scotland. The Authority intends to award this Lot as a single

supplier framework. Full details of Goods and volumes can be found within the ITT documents.

Delivery: Scotland · All entities constituted pursuant to the National Health Service (Scotland) Act 1978, and any Integrated Joint Boards established pursuant to the new Public Bodies (Joint Working) Scotland Act 2014.
Extensions: This framework includes the option to extend for any number of periods, up to a maximum overall period of twenty-four (24) months upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire.Variant bids: not allowed
33600000 Pharmaceutical products
Lot #6Cytarabine InjectionsAwardedRenewalPublished value£79,599

Supply of Cytarabine Injections to NHS Scotland. The Authority intends to award this Lot as a single supplier framework. Full details of

Goods and volumes can be found within the ITT documents.

Delivery: Scotland · All entities constituted pursuant to the National Health Service (Scotland) Act 1978, and any Integrated Joint Boards established pursuant to the new Public Bodies (Joint Working) Scotland Act 2014.
Extensions: This framework includes the option to extend for any number of periods, up to a maximum overall period of twenty-four (24) months upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire.Variant bids: not allowed
33600000 Pharmaceutical products
Lot #7Dacarbazine InjectionsAwardedRenewalPublished value£257,544

Supply of Dacarbazine Injections to NHS Scotland. The Authority intends to award this Lot as a single supplier framework. Full details of

Goods and volumes can be found within the ITT documents.

Delivery: Scotland · All entities constituted pursuant to the National Health Service (Scotland) Act 1978, and any Integrated Joint Boards established pursuant to the new Public Bodies (Joint Working) Scotland Act 2014.
Extensions: This framework includes the option to extend for any number of periods, up to a maximum overall period of twenty-four (24) months upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire.Variant bids: not allowed
33600000 Pharmaceutical products
Lot #8Disodium Folinate InjectionsAwardedRenewalPublished value£291,108

Supply of Disodium Folinate Injections to NHS Scotland. The Authority intends to award this Lot as a single supplier framework. Full

details of Goods and volumes can be found within the ITT documents.

Delivery: Scotland · All entities constituted pursuant to the National Health Service (Scotland) Act 1978, and any Integrated Joint Boards established pursuant to the new Public Bodies (Joint Working) Scotland Act 2014
Extensions: This framework includes the option to extend for any number of periods, up to a maximum overall period of twenty-four (24) months upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire.Variant bids: not allowed
33600000 Pharmaceutical products
Lot #9Docetaxel Concentrate For Solution For InfusionAwardedRenewalPublished value£263,871

Supply of Docetaxel Concentrate For Solution For Infusion to NHS Scotland. The Authority intends to award this Lot as a single supplier

framework. Full details of Goods and volumes can be found within the ITT documents.

Delivery: Scotland · All entities constituted pursuant to the National Health Service (Scotland) Act 1978, and any Integrated Joint Boards established pursuant to the new Public Bodies (Joint Working) Scotland Act 2014.
Extensions: This framework includes the option to extend for any number of periods, up to a maximum overall period of twenty-four (24) months upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire.Variant bids: not allowed
33600000 Pharmaceutical products
Lot #10Doxorubicin Solution For Injection VialsAwardedRenewalPublished value£64,886

Supply of Doxorubicin Solution For Injection Vials to NHS Scotland. The Authority intends to award this Lot as a single supplier

framework. Full details of Goods and volumes can be found within the ITT documents.

Delivery: Scotland · All entities constituted pursuant to the National Health Service (Scotland) Act 1978, and any Integrated Joint Boards established pursuant to the new Public Bodies (Joint Working) Scotland Act 2014.
Extensions: This framework includes the option to extend for any number of periods, up to a maximum overall period of twenty-four (24) months upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire.Variant bids: not allowed
33600000 Pharmaceutical products
Lot #11Fluorouracil 25MG/ML InjectionsCancelledRenewalPublished value£61,696

Supply of Fluorouracil Injections to NHS Scotland. The Authority intends to award this Lot as a single supplier framework. Full details of

Goods and volumes can be found within the ITT documents

Delivery: Scotland · All entities constituted pursuant to the National Health Service (Scotland) Act 1978, and any Integrated Joint Boards established pursuant to the new Public Bodies (Joint Working) Scotland Act 2014.
Extensions: This framework includes the option to extend for any number of periods, up to a maximum overall period of twenty-four (24) months upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire.Variant bids: not allowed
33600000 Pharmaceutical products
Lot #12Fluorouracil 50MG/ML InjectionsAwardedRenewalPublished value£299,132

Supply of Fluorouracil 50MG/ML Injection to NHS Scotland. The Authority intends to award this Lot as a single supplier framework. Full

details of Goods and volumes can be found within the ITT documents.

Delivery: Scotland · All entities constituted pursuant to the National Health Service (Scotland) Act 1978, and any Integrated Joint Boards established pursuant to the new Public Bodies (Joint Working) Scotland Act 2014
Extensions: This framework includes the option to extend for any number of periods, up to a maximum overall period of twenty-four (24) months upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire.Variant bids: not allowed
33600000 Pharmaceutical products
Lot #13Gemcitabine 38MG/ML Concentrate For Solution For Infusion VialsAwardedRenewalPublished value£117,507

Supply of Gemcitabine 38MG/ML Concentrate For Solution For Infusion Vials to NHS Scotland. The Authority intends to award this Lot

as a single supplier framework. Full details of Goods and volumes can be found within the ITT documents

Delivery: Scotland · All entities constituted pursuant to the National Health Service (Scotland) Act 1978, and any Integrated Joint Boards established pursuant to the new Public Bodies (Joint Working) Scotland Act 2014
Extensions: This framework includes the option to extend for any number of periods, up to a maximum overall period of twenty-four (24) months upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire.Variant bids: not allowed
33600000 Pharmaceutical products
Lot #14Gemcitabine 100MG/ML Concentrate For Solution For Infusion VialsCancelledRenewalPublished value£49,716

Supply of Gemcitabine 100MG/ML Concentrate For Solution For Infusion Vials to NHS Scotland. The Authority intends to award this Lot

as a single supplier framework. Full details of Goods and volumes can be found within the ITT documents.

Delivery: Scotland · All entities constituted pursuant to the National Health Service (Scotland) Act 1978, and any Integrated Joint Boards established pursuant to the new Public Bodies (Joint Working) Scotland Act 2014.
Extensions: This framework includes the option to extend for any number of periods, up to a maximum overall period of twenty-four (24) months upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire.Variant bids: not allowed
33600000 Pharmaceutical products
Lot #15Gemcitabine Powder For Solution For Infusion VialsCancelledRenewalPublished value£240,009

Supply of Gemcitabine Powder For Solution For Infusion Vials to NHS Scotland. The Authority intends to award this Lot as a single

supplier framework. Full details of Goods and volumes can be found within the ITT documents

Delivery: Scotland · All entities constituted pursuant to the National Health Service (Scotland) Act 1978, and any Integrated Joint Boards established pursuant to the new Public Bodies (Joint Working) Scotland Act 2014.
Extensions: This framework includes the option to extend for any number of periods, up to a maximum overall period of twenty-four (24) months upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire.Variant bids: not allowed
33600000 Pharmaceutical products
Lot #16Idarubicin Hydrochloride Injection Powder For ReconstitutionCancelledRenewalPublished value£105,985

Supply of Idarubicin Hydrochloride Injection Powder For Reconstitution to NHS Scotland. The Authority intends to award this Lot as a

single supplier framework. Full details of Goods and volumes can be found within the ITT documents.

Delivery: Scotland · All entities constituted pursuant to the National Health Service (Scotland) Act 1978, and any Integrated Joint Boards established pursuant to the new Public Bodies (Joint Working) Scotland Act 2014.
Extensions: This framework includes the option to extend for any number of periods, up to a maximum overall period of twenty-four (24) months upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire.Variant bids: not allowed
33600000 Pharmaceutical products
Lot #17Ifosfamide Injection Powder For ReconstitutionAwardedRenewalPublished value£1,765,159

Supply of Ifosfamide Injection Powder For Reconstitution to NHS Scotland. The Authority intends to award this Lot as a single supplier

framework. Full details of Goods and volumes can be found within the ITT documents.

Delivery: Scotland · All entities constituted pursuant to the National Health Service (Scotland) Act 1978, and any Integrated Joint Boards established pursuant to the new Public Bodies (Joint Working) Scotland Act 2014
Extensions: This framework includes the option to extend for any number of periods, up to a maximum overall period of twenty-four (24) months upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire.Variant bids: not allowed
33600000 Pharmaceutical products
Lot #18Irinotecan Hydrochloride InjectionsAwardedRenewalPublished value£244,363

Supply of Irinotecan Hydrochloride Injections to NHS Scotland. The Authority intends to award this Lot as a single supplier framework.

Full details of Goods and volumes can be found within the ITT documents.

Delivery: Scotland · All entities constituted pursuant to the National Health Service (Scotland) Act 1978, and any Integrated Joint Boards established pursuant to the new Public Bodies (Joint Working) Scotland Act 2014
Extensions: This framework includes the option to extend for any number of periods, up to a maximum overall period of twenty-four (24) months upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire.Variant bids: not allowed
33600000 Pharmaceutical products
Lot #19Lanreotide Injection Prefilled Syringes (unbundled - without homecare)AwardedRenewalceiling above

Supply of Lanreotide Injection Prefilled Syringes (unbundled - without homecare). The Authority intends to award this Lot as a unranked

multi-supplier framework to a maximum of three (3) Framework Participants. Full details of Goods and volumes can be found within the

ITT documents

Delivery: Scotland · All entities constituted pursuant to the National Health Service (Scotland) Act 1978, and any Integrated Joint Boards established pursuant to the new Public Bodies (Joint Working) Scotland Act 2014.
Extensions: This framework includes the option to extend for any number of periods, up to a maximum overall period of twenty-four (24) months upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire.Variant bids: not allowed
33600000 Pharmaceutical products
Lot #20Lanreotide Injection Prefilled Syringes (bundled - with homecare)AwardedRenewalceiling above

Supply of Lanreotide Injection Prefilled Syringes (bundled - with homecare) to NHS Scotland. The Authority intends to award this Lot as a

unranked multi-supplier framework to a maximum of three (3) Framework Participants. Full details of Goods and volumes can be found

within the ITT documents.

Delivery: Scotland · All entities constituted pursuant to the National Health Service (Scotland) Act 1978, and any Integrated Joint Boards established pursuant to the new Public Bodies (Joint Working) Scotland Act 2014.
Extensions: This framework includes the option to extend for any number of periods, up to a maximum overall period of twenty-four (24) months upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire.Variant bids: not allowed
33600000 Pharmaceutical products
Lot #21Methotrexate Without Preservatives InjectionsAwardedRenewalPublished value£325,008

Supply of Methotrexate Without Preservatives Injection to NHS Scotland. The Authority intends to award this Lot as a single supplier

framework. Full details of Goods and volumes can be found within the ITT documents

Delivery: Scotland · All entities constituted pursuant to the National Health Service (Scotland) Act 1978, and any Integrated Joint Boards established pursuant to the new Public Bodies (Joint Working) Scotland Act 2014.
Extensions: This framework includes the option to extend for any number of periods, up to a maximum overall period of twenty-four (24) months upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire.Variant bids: not allowed
33600000 Pharmaceutical products
Lot #22Methotrexate Oral SolutionAwardedRenewalPublished value£39,204

Supply of Methotrexate Oral Solution to NHS Scotland. The Authority intends to award this Lot as a single supplier framework. Full

details of Goods and volumes can be found within the ITT documents.

Delivery: Scotland · All entities constituted pursuant to the National Health Service (Scotland) Act 1978, and any Integrated Joint Boards established pursuant to the new Public Bodies (Joint Working) Scotland Act 2014.
Extensions: This framework includes the option to extend for any number of periods, up to a maximum overall period of twenty-four (24) months upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire.Variant bids: not allowed
33600000 Pharmaceutical products
Lot #23Oxaliplatin Vial SolutionAwardedRenewalPublished value£157,351

Supply of Oxaliplatin Vial Solution to NHS Scotland. The Authority intends to award this Lot as a single supplier framework. Full details

of Goods and volumes can be found within the ITT documents.

Delivery: Scotland · All entities constituted pursuant to the National Health Service (Scotland) Act 1978, and any Integrated Joint Boards established pursuant to the new Public Bodies (Joint Working) Scotland Act 2014.
Extensions: This framework includes the option to extend for any number of periods, up to a maximum overall period of twenty-four (24) months upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire.Variant bids: not allowed
33600000 Pharmaceutical products
Lot #24Paclitaxel Concentrate For Intravenous InfusionAwardedRenewalPublished value£442,323

Supply of Paclitaxel Concentrate For Intravenous Infusion to NHS Scotland. The Authority intends to award this Lot as a single supplier

framework. Full details of Goods and volumes can be found within the ITT documents

Delivery: Scotland · All entities constituted pursuant to the National Health Service (Scotland) Act 1978, and any Integrated Joint Boards established pursuant to the new Public Bodies (Joint Working) Scotland Act 2014.
Extensions: This framework includes the option to extend for any number of periods, up to a maximum overall period of twenty-four (24) months upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire.Variant bids: not allowed
33600000 Pharmaceutical products
Lot #25Temozolomide CapsulesAwardedRenewalPublished value£108,280

Supply of Temozolomide Capsules to NHS Scotland. The Authority intends to award this Lot as a single supplier framework. Full details

of Goods and volumes can be found within the ITT documents.

Delivery: Scotland · All entities constituted pursuant to the National Health Service (Scotland) Act 1978, and any Integrated Joint Boards established pursuant to the new Public Bodies (Joint Working) Scotland Act 2014.
Extensions: This framework includes the option to extend for any number of periods, up to a maximum overall period of twenty-four (24) months upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire.Variant bids: not allowed
33600000 Pharmaceutical products

What it takes to win
i

How this buyer will score bids.

The evaluation criteria and weights exactly as published on the notice, grouped by family (price, quality, social value and so on).

Evaluation split and conditions of participation as published; the tender pack may add more
How bids were scored · same split on all 43 lots
Quality: 5%Price: 95%
Published sub-criteria (2)
  • Logistics: 5%
  • price: 95%
Published award criteria (2)
  • Logistics: 5
  • Price: 95
Conditions of participation2
  • Suitability

    Economic operators may be excluded from this competition if they are in breach of any situation referred to in regulation 58 of the Public Contracts (Scotland) Regulations 2015

  • Technical & professional ability

    (a) Potential Framework Participants must be able to demonstrate the existence of a valid and current UK Marketing Authorisation (PL, PLGB, or PLPI number) that has been approved by the MHRA for all tendered Medicines at the date of submission of the tender bar the following medicines; Bosutinib, Eribulin, Paclitaxel Albumin. For these medicines, potential framework participants must be able to demonstrate the existence of a valid and current UK marketing authorization (PL, PLGB, or PLPI) that has been approved by the MHRA by the date of commencement of the framework agreement.

    (b) Potential Framework Participants and any sub-contractor(s) must possess valid certification of BS EN ISO 9001 or equivalent.

    (c) All tendered Goods must comply with the MHRA best Practice Guidance on Labelling and Packaging and the National Patient Safety Agency ("NPSA") Guidelines on Packaging and Labelling on pack design.

    (d) Potential Framework Participants are required to provide evidence that their organisation has taken steps to build their awareness of the climate change emergency and how they will respond.

    Minimum: (a) Confirmation of existence of a valid and current UK Marketing Authorisation (PL, PLGB, PLPI number) that has been approved by the MHRA for all tendered Medicines at the date of submission of the tender (bar the following medicines; Bosutinib, Eribulin, Paclitaxel Albumin whic…
What this means for your bid
  • Price carries 95 of 100 points: a 10% discount moves about 9.5 points. This one is won on the number: sharpen the price before polishing the prose.
  • “NP39724 Generic and Biosimilar Cancer Medicines” is a framework: the contest is a place on its panel, not a single contract.

Price arithmetic assumes straight proportional scoring; the tender pack may use another formula.

Procedure terms & legal framework

From the official record · publisher note attached
Procedure method
Open procedure
Legal basis
CELEX · 32014L0024 Public Contracts Regulations 2015 (Directive 2014/24/EU)
Procurement category
Goods
Notice status
Awarded
Procurement threshold
Unspecified in notice
Regulatory regime
Standard
Commercial structure
Framework agreement
Who may use this agreement
Not stated in the notice; call-off rights may be limited to the establishing authority
Competition type
Competitive procedure
GPA / WTO covered
Yes (GPA)
Recurring procurement
No (one-off requirement)
First published
2 Aug 2024, 10:51 BST
Last source update
27 Feb 2025, 09:17 GMT
Award evaluation window
2 Sept 2024 – …
Authority reference
NP39724
FTS notice number
2025/S 000-007352
Classification (CPV)
Pharmaceutical products
Delivery area
UKScotland (UKM)
Official registry OCID
ocds-h6vhtk-04870b Find a Tender
Contract terms
Electronic trading
e-invoicing allowed · electronic ordering · electronic payment
Review and risk notes
Review procedure

Economic operators should approach the contracting authority in the first instance. However, the only formal remedy is to apply to the courts:

An economic operator that suffers, or is at risk of suffering, loss, or damage attributable to a breach of duty under the Public Contracts (Scotland) Regulations 2015 or the Procurement Reform (Scotland) Act 2014, may bring proceedings in the Sheriff Court or the Court of Session.

The bringing of court proceedings against the Authority after the Framework Agreement has been entered into will not affect the Framework Agreement unless grounds for the imposition of special penalties under the Public Contracts (Scotland) Regulations 2015 can be established. Otherwise, the remedies that may be awarded by the courts where the Framework Agreement has been entered into are limited to the award of damages.

Publisher note: The estimated value(s) referred to in Section II.1.7 and Section V.2.4 covers the twenty-four (24) month Framework Agreement duration and the twenty-four (24) month extension period of the Framework Agreement. Details of individual lines awarded within a specific Lot can be requested from the named person at the head of this notice. (SC Ref:790367)

How it was run

Official notice
Run through: Public Contracts Scotland · Who buys & how to bid on PCS
Supplier login requiredLanguage: EN
Access & registration note: Free single registration for Scotland; PCS-Tender (Jaggaer) for full bidding
Appointment period ends
2 Sept 2024, 12:00 BST
Submission channel
{"electronicSubmission"}
Accepted languages
en
Bids opened
2 Sept 2024, 12:00 BST
Detailed submission instructions & authority contactsFrom official release

www.publictendersscotland.publiccontractsscotland.gov.uk/web/login.html ↗

Timeline

2 Sept 2024 → 27 Feb 2025 · 3 dates
  1. Admission / appointment period endsperiod end, not a bid countdown
    2 Sept 2024, 12:00 BST
  2. Bids opened
    2 Sept 2024, 12:00 BST
  3. Notice published
    27 Feb 2025, 09:17 GMT

Notice history

2 events · 2 releases on Find a Tender · since 27 Feb 2025
  1. Status changed to complete
    27 Feb 2025, 09:17 GMT
  2. Buyer details updated
    27 Feb 2025, 09:17 GMT

Commercial outcome & contract awards

Published awards, contracts and bid statistics, not a forecast
Suppliers appointed 35admitted to the panel · see the list ↓
Bids received 4busiest of 25 lots
Contracts signed 20latest 13 Jan 2025

35 suppliers are admitted to this framework without individual award values or dates, see the supplier list below.

Contracts

  • Bendamustine Powder For Solution For Infusion

    Signed
    13 Jan 2025
    Value
    £30,764
    Status
    active

  • Cytarabine Injections

    Signed
    13 Jan 2025
    Value
    £26,461
    Status
    active

  • Dacarbazine Injections

    Signed
    13 Jan 2025
    Value
    £71,718
    Status
    active

  • Disodium Folinate Injections

    Signed
    13 Jan 2025
    Value
    £72,777
    Status
    active

  • Docetaxel Concentrate For Solution For Infusion

    Signed
    13 Jan 2025
    Value
    £70,677
    Status
    active

  • Doxorubicin Solution For Injection Vials

    Signed
    13 Jan 2025
    Value
    £14,717
    Status
    active

  • Fluorouracil 50MG/ML Injections

    Signed
    13 Jan 2025
    Value
    £75,886
    Status
    active

  • Gemcitabine 38MG/ML Concentrate For Solution For Infusion Vials

    Signed
    13 Jan 2025
    Value
    £29,968
    Status
    active

  • Ifosfamide Injection Powder For Reconstitution

    Signed
    13 Jan 2025
    Value
    £461,565
    Status
    active

  • Irinotecan Hydrochloride Injections

    Signed
    13 Jan 2025
    Value
    £64,662
    Status
    active

  • Capecitabine Tablets

    Signed
    13 Jan 2025
    Value
    £159,229
    Status
    active

  • Lanreotide Injection Prefilled Syringes (unbundled - without homecare)

    Signed
    13 Jan 2025
    Value
    £1,324,548
    Status
    active

  • Lanreotide Injection Prefilled Syringes (bundled - with homecare)

    Signed
    13 Jan 2025
    Value
    £681,188
    Status
    active

  • Methotrexate Without Preservatives Injections

    Signed
    13 Jan 2025
    Value
    £83,938
    Status
    active

  • Methotrexate Oral Solution

    Signed
    13 Jan 2025
    Value
    £9,476
    Status
    active

  • Oxaliplatin Vial Solution

    Signed
    13 Jan 2025
    Value
    £40,456
    Status
    active

  • Paclitaxel Concentrate For Intravenous Infusion

    Signed
    13 Jan 2025
    Value
    £110,289
    Status
    active

  • Temozolomide Capsules

    Signed
    13 Jan 2025
    Value
    £26,940
    Status
    active

  • Vincristine Without Preservatives Injection

    Signed
    13 Jan 2025
    Value
    £24,879
    Status
    active

  • Vinorelbine Injections

    Signed
    13 Jan 2025
    Value
    £11,323
    Status
    active

Bid statistics published by the authority

LotBidsSMEVCSEValid bid range
1 · Bendamustine Powder For Solution For Infusion2bids · 2 electronic · 2 from abroad0——
2 · Capecitabine Tablets4bids · 4 electronic · 4 from abroad0——
3 · Carboplatin Injections3bids · 3 electronic · 3 from abroad0——
4 · Cisplatin Injections1bids · 1 electronic · 1 from abroad0——
5 · Cyclophosphamide Injection, Powder For Reconstitution3bids · 3 electronic · 3 from abroad0——
6 · Cytarabine Injections2bids · 2 electronic · 2 from abroad0——
7 · Dacarbazine Injections1bids · 1 electronic · 1 from abroad0——
8 · Disodium Folinate Injections1bids · 1 electronic · 1 from abroad0——
9 · Docetaxel Concentrate For Solution For Infusion2bids · 2 electronic · 2 from abroad0——
10 · Doxorubicin Solution For Injection Vials3bids · 3 electronic · 3 from abroad0——
12 · Fluorouracil 50MG/ML Injections2bids · 2 electronic · 2 from abroad0——
13 · Gemcitabine 38MG/ML Concentrate For Solution For Infusion Vials2bids · 2 electronic · 2 from abroad0——
17 · Ifosfamide Injection Powder For Reconstitution2bids · 2 electronic · 2 from abroad0——
18 · Irinotecan Hydrochloride Injections4bids · 0 electronic · 4 from abroad0——
19 · Lanreotide Injection Prefilled Syringes (unbundled - without homecare)2bids · 2 electronic · 2 from abroad0——
20 · Lanreotide Injection Prefilled Syringes (bundled - with homecare)2bids · 2 electronic · 2 from abroad0——
21 · Methotrexate Without Preservatives Injections2bids · 2 electronic · 2 from abroad0——
22 · Methotrexate Oral Solution2bids · 2 electronic · 2 from abroad0——
23 · Oxaliplatin Vial Solution3bids · 3 electronic · 3 from abroad0——
24 · Paclitaxel Concentrate For Intravenous Infusion2bids · 2 electronic · 2 from abroad0——
25 · Temozolomide Capsules2bids · 2 electronic · 2 from abroad0——
Lot 262bids · 2 electronic · 2 from abroad0——
Lot 271bids · 1 electronic · 1 from abroad0——
Lot 302bids · 2 electronic · 2 from abroad0——
Lot 323bids · 3 electronic · 3 from abroad0——

Contracting authority & participating public bodies

2 public bodies on the notice

The Common Services Agency (more commonly known as NHS National Services Scotland) (NSS)

Contracting authorityNHS & healthcareBody governed by public lawHealth 1 South Gyle Crescent, Edinburgh, Scotland, EH12 9EBContact email, phone

Framework contractors & participating bidders

37 commercial parties on the notice
  • Accord-UK LtdFramework contractor Whiddon Valley, Barnstaple, Devon, South West, EX32 8NSContact phone
  • Aspen Pharmacare UK LimitedFramework contractor OFFICE 419-420 4TH FLOOR ONE KINGDOM STREET, Paddington, London, UK, W26bdContact phone
  • Aspire Pharma LtdFramework contractor 4 Rotherbrook Court, Bedford Road, Petersfield, UK, GU32 3QG
  • Baxter Healthcare LtdFramework contractor Wallingford Road, Compton,, Newbury, Berkshire, UK, RG20 7QWContact phone
  • CST Pharma LtdFramework contractor Unit 5-7, Westgate Park Industrial Estate, Tintagel Way, Walsall, UK, WS9 8ER
  • Celix Pharma Ltd.Framework contractor 12 Constance Street, International House, London, London, E16 2DQContact phone
  • Celltrion Healthcare United Kingdom LimitedFramework contractor 1-7 The Switch, Slough, UK, SL1 1QPContact phone
  • Chugai Pharma UK LtdFramework contractor Mulliner House, Flanders Road, London, UK, W4 1NN
  • Cipla EU LtdFramework contractor Floor 3, 364 - 366 Kensington High Street, London, UK, W14 8NSContact phone
  • Day Lewis Medical LtdFramework contractor Day Lewis House, 2 Peterwood Way, Croydon, UK, CR0 4UQContact phone
Show 27 more suppliers
  • Dr Reddy's Laboratories (UK) LtdFramework contractor 410, Cambridge Science Park,, Milton Road, Milton,, Cambridge, UK, CB4 0PEContact phone
  • Esteve Pharmaceuticals LtdFramework contractor The Courtyard Barns,, Choke Lane, Cookham Dean,, Maidenhead,, South East, SL6 6PTContact phone
  • Flexipharm Austrading LimitedFramework contractor ATI House, 6 Boston Drive, Bourne End, UK, SL8 5YSContact phone
  • Fresenius Kabi LimitedFramework contractor Cestrian Court, Eastgate Way, Manor Park, Runcorn, UK, WA7 1NTContact phone
  • Fresenius Kabi LtdFramework contractor Cestrian Court, Eastgate Way,, Manor Park, Runcorn, Cheshire, Runcorn, UK, WA7 1NT
  • Glenmark Pharmaceuticals Europe LtdFramework contractor Building 2, Croxley Green Business Park, Watford, UK, WD18 8YAContact phone
  • Ipsen LtdFramework contractor 5th Floor The Point, 37 North Wharf Road, London, UK, W2 1AFContact phone
  • MSN LabsFramework contractor Works Road, LETCHWORTH GARDEN CITY, UK, SG6 1GJContact phone
  • Martindale PharmaFramework contractor Bampton Road, Harold Hill, Romford, UK, RM3 8UGContact phone
  • Mercury Pharmaceuticals LimitedFramework contractor Dashwood House, , 2nd Floor, 69 Old Broad Street,, London, United Kingdom., London, EC2M 1QSContact phone
  • Morningside Pharmaceuticals LimitedFramework contractor 5 Pavilion Way, Castle Business Park, Loughborough, Leicestershire, UK, LE11 5GWContact phone
  • Neon HealthcareFramework contractor 8 The Chase, John Tate Road, Foxholes Business Park, Hertford, East of England, SG13 7NNContact phone
  • Organon Pharma (UK) Ltd.Framework contractor The Hewett Building , 14 Hewett Street, London, UK, EC2A 3NPContact phone
  • Pfizer LtdFramework contractor Walton Oaks, Dorking Road, Tadworth, UK, KT20 7NSContact phone
  • Ranbaxy UK LtdFramework contractor Building 4 Chiswick Park, 566 Chiswick High Road, London, UK, W4 5YE
  • Roche Products LtdFramework contractor 6 Falcon Way, Shire Park, Welwyn Garden City, UK, AL7 1TWContact phone
  • Rosemont PharmaceuticalsFramework contractor Braithwaite Street, Leeds, Yorkshire & Humber, LS11 9XEContact phone
  • STADA UK - Thornton & RossFramework contractor Linthwaite, Huddersfield, UK, HD7 5JNContact phone
  • SandozFramework contractor Park View, Riverside Way, Watchmoor Park, Camberley, Surrey, UK, GU15 3YLContact phone
  • Seacross PharmaceuticalsFramework contractor Stanmore Business & Innovation Centre, , Stanmore Place, Honeypot Lane, London, London, HA7 1BTContact phone
  • Selective Supplies LtdFramework contractor The Priory, Syresham Gardens, Haywards Heath, UK, RH16 3LB
  • Teva UK LtdFramework contractor Ridings Point, Whistler Drive, Glasshoughton, Castleford, UK, WF10 5HXContact phone
  • Tillomed Laboratories LtdFramework contractor 220 Butterfield, Great Marling, Luton, UK, LU2 8DL
  • Tillomed Laboratories ltdFramework contractor 220 Butterfield , Great Marlings, Luton, UK, LU2 8DLContact phone
  • Viatris UK Healthcare LtdFramework contractor Building 4, Trident Place, Mosquito Way, Hatfield, East of England, AL10 9ULContact phone
  • Zentiva UKFramework contractor First Floor, United Kingdom, Andrews House College Road, Guildford England, UK, GU1 4QBContact phone
  • medac Pharma LLPFramework contractor Scion House, Innovation Park, Stirling, UK, FK9 4NFContact phone

Official documents & specifications

Official links; attachments are not copied

No document links were published on the notice.